All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sitesPotential first and only pharmacological treatment for the most prominent neurologic ...
Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder March 5, 2026 7:30 AM ESTCompany ParticipantsMichael Cola - ...
Abstract: We propose a novel low-loss phase-change optical switch using MnTe thin film, which has a smaller absorption coefficient than conventional phase-change materials. The designed phase-change ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果